Broadening the baseline | Laboratory News
As the technology underpinning genome studies continues to improve, an over-reliance on Eurocentric datasets holds research back, asserts…
NHS to screen newborns in England for rare genetic disorder
Hereditary tyrosinaemia type 1 (HT1) affects around one in seven babies a year in the UK. It prevents…
CRISPR Gene Editing Breakthrough in Treating Sickle Cell Disease
Gene editing is a cutting-edge scientific technology that allows precise modifications to DNA. Much like how strategies evolve…
New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color
Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
NHS to screen newborns in England for rare genetic disorder
Hereditary tyrosinaemia type 1 (HT1) affects around one in seven babies a year in the UK. It prevents…
Application Of CRISPR Technology In iPSC Gene Correction
By Jack (Jie) Huang, M.D., Ph.D. The rise of induced pluripotent stem cell (iPSC) technology has opened up…
New SDR-Seq Tool Links DNA Variants to Disease
Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain diseases ‘ran…
NHS to screen newborns in England for rare genetic disorder
Dr Harrison Carter, NHS director of vaccination and screening, said: “Being able to screen for tyrosinaemia will help…
How genomic screening in newborns found 16 hidden disorders standard tests overlooked
By uncovering life-altering genetic conditions before symptoms appear, genomic screening could redefine newborn care if health systems can…
Las Cruces medical center introduces genetic testing to boost cancer prevention efforts
LAS CRUCES, N.M. (KFOX14/CBS4) — Memorial Medical Center in Las Cruces is introducing a new genetic testing tool…
NHS to screen newborns in England for rare genetic disorder
Hereditary tyrosinaemia type 1 (HT1) affects around one in seven babies a year in the UK. It prevents…
CRISPR Therapeutics Presents New Preclinical Data for CTX460™ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase™ Editing Platform
CRISPR Therapeutics AG -Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a…